GE HealthCare Technologies Inc. Stock
Equities
GEHC
US36266G1076
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.77 USD | -2.59% |
|
-2.42% | -2.74% |
| Capitalization | 36.34B 30.9B 28.65B 26.77B 49.9B 3,338B 52.89B 327B 130B 1,576B 136B 133B 5,734B | P/E ratio 2025 * |
17.4x | P/E ratio 2026 * | 17x |
|---|---|---|---|---|---|
| Enterprise value | 41.36B 35.18B 32.61B 30.47B 56.8B 3,800B 60.21B 373B 148B 1,794B 155B 152B 6,527B | EV / Sales 2025 * |
2.02x | EV / Sales 2026 * | 1.87x |
| Free-Float |
96.76% | Yield 2025 * |
0.17% | Yield 2026 * | 0.2% |
Last Transcript: GE HealthCare Technologies Inc.
| 1 day | -2.59% | ||
| 1 week | -2.42% | ||
| Current month | -2.74% | ||
| 1 month | -4.26% | ||
| 3 months | +3.25% | ||
| 6 months | +3.26% | ||
| Current year | -2.74% |
| 1 week | 78.31 |  | 83.21 |
| 1 month | 78.31 | | 89.77 |
| Current year | 78.31 | | 89.77 |
| 1 year | 57.65 | | 94.8 |
| 3 years | 57.65 | | 94.8 |
| 5 years | 53 | | 94.8 |
| 10 years | 53 | | 94.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Arduini
CEO | Chief Executive Officer | 61 | 14/12/2022 |
James Saccaro
DFI | Director of Finance/CFO | 53 | 01/06/2023 |
Taha Kass-Hout
CTO | Chief Tech/Sci/R&D Officer | - | 05/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Arduini
BRD | Director/Board Member | 61 | 14/12/2022 |
Catherine Lesjak
BRD | Director/Board Member | 67 | 14/12/2022 |
Rodney Hochman
BRD | Director/Board Member | 70 | 03/01/2023 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.59% | -2.42% | -9.52% | +14.74% | 36.34B | |
| -2.11% | +1.17% | +8.89% | +3.50% | 235B | |
| -0.35% | -2.06% | -13.91% | +104.70% | 186B | |
| -2.11% | -0.42% | -4.34% | -15.16% | 166B | |
| +1.34% | +5.04% | -8.98% | +101.77% | 137B | |
| -1.84% | -6.48% | -20.32% | -11.63% | 56.8B | |
| -0.92% | -0.82% | +21.37% | +4.50% | 48.55B | |
| -2.58% | -3.29% | -11.41% | -15.09% | 38.29B | |
| -1.16% | -2.02% | +1.41% | +6.70% | 36.76B | |
| +1.04% | -2.82% | -16.21% | -42.67% | 33.96B | |
| Average | -1.13% | -1.19% | -5.30% | +15.13% | 97.48B | |
| Weighted average by Cap. | -1.10% | +0.06% | -3.94% | +30.80% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 20.52B 17.46B 16.18B 15.12B 28.19B 1,886B 29.87B 185B 73.41B 890B 76.96B 75.38B 3,239B | 21.41B 18.21B 16.88B 15.78B 29.41B 1,967B 31.17B 193B 76.6B 929B 80.3B 78.66B 3,379B |
| Net income | 2.11B 1.79B 1.66B 1.55B 2.89B 194B 3.07B 18.98B 7.54B 91.4B 7.9B 7.74B 332B | 2.17B 1.85B 1.71B 1.6B 2.98B 199B 3.16B 19.55B 7.76B 94.11B 8.14B 7.97B 342B |
| Net Debt | 5.03B 4.27B 3.96B 3.7B 6.9B 462B 7.31B 45.28B 17.97B 218B 18.84B 18.46B 793B | 3.62B 3.08B 2.86B 2.67B 4.98B 333B 5.28B 32.66B 12.97B 157B 13.59B 13.31B 572B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 79.77 $ | -2.59% | 2,340,872 |
| 22/01/26 | 81.89 $ | +0.97% | 5,526,305 |
| 21/01/26 | 81.10 $ | +2.88% | 4,418,945 |
| 20/01/26 | 78.83 $ | -3.57% | 5,702,780 |
| 16/01/26 | 81.75 $ | -0.92% | 6,127,067 |
Delayed Quote Nasdaq, January 24, 2026 at 05:00 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GEHC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition